Skip to main content

Peer Review reports

From: Long-term effects of natalizumab on MRI activity and clinical outcomes in Japanese patients with relapsing-remitting multiple sclerosis

Original Submission
14 Dec 2022 Submitted Original manuscript
19 Jan 2023 Reviewed Reviewer Report
22 Feb 2023 Reviewed Reviewer Report
15 May 2023 Author responded Author comments - Takahiko Saida
Resubmission - Version 2
15 May 2023 Submitted Manuscript version 2
24 May 2023 Author responded Author comments - Takahiko Saida
Resubmission - Version 3
24 May 2023 Submitted Manuscript version 3
30 May 2023 Author responded Author comments - Takahiko Saida
Resubmission - Version 4
30 May 2023 Submitted Manuscript version 4
2 Jun 2023 Reviewed Reviewer Report
16 Jun 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
20 Jun 2023 Editorially accepted
29 Aug 2023 Article published 10.1186/s12883-023-03297-1

You can find further information about peer review here.

Back to article page